about
Engineering of routes to heparin and related polysaccharidesRecent advances in cellular glycomic analyses.High sodium diet converts renal proteoglycans into pro-inflammatory mediators in ratsCapillary electrophoresis for total glycosaminoglycan analysis.Heparinase 1 selectivity for the 3,6-di-O-sulfo-2-deoxy-2-sulfamido-alpha-D-glucopyranose (1,4) 2-O-sulfo-alpha-L-idopyranosyluronic acid (GlcNS3S6S-IdoA2S) linkages.Glycomics hits the big timeHeparin mapping using heparin lyases and the generation of a novel low molecular weight heparinFGF-FGFR signaling mediated through glycosaminoglycans in microtiter plate and cell-based microarray platforms.The proteoglycan bikunin has a defined sequence.High-performance liquid chromatography-mass spectrometry for mapping and sequencing glycosaminoglycan-derived oligosaccharides.Proteoglycan sequenceSignal amplification by glyco-qPCR for ultrasensitive detection of carbohydrates: applications in glycobiology.Targeting the glycoproteomeAnalysis of Total Human Urinary Glycosaminoglycan Disaccharides by Liquid Chromatography-Tandem Mass SpectrometryPerspectives on Anti-Glycan Antibodies Gleaned from Development of a Community Resource DatabaseCell-Based Microscale Isolation of Glycoaminoglycans for Glycomics Study.Fibroblast growth factor-based signaling through synthetic heparan sulfate blocks copolymers studied using high cell density three-dimensional cell printingCarbohydrate-containing molecules as potential biomarkers in colon cancer.Changes in glycosaminoglycan structure on differentiation of human embryonic stem cells towards mesoderm and endoderm lineages.Studying Salmonellae and Yersiniae host-pathogen interactions using integrated 'omics and modeling.Proteoglycans in stem cells.Molecular deciphering of the ABO system as a basis for novel diagnostics and therapeutics in ABO incompatible transplantation.Differential Characterization and Classification of Tissue Specific Glycosaminoglycans by Tandem Mass Spectrometry and Statistical Methods.Glycans and glycoproteins as specific biomarkers for cancer.Anti-inflammatory effect of glycosaminoglycan derived from Gryllus bimaculatus (a type of cricket, insect) on adjuvant-treated chronic arthritis rat model.Heparin-polynitroxide derivatives: a platform for new diagnostic and therapeutic agents in cardiovascular disease?Characterization of Glycan Structures of Chondroitin Sulfate-Glycopeptides Facilitated by Sodium Ion-Pairing and Positive Mode LC-MS/MS.Assays for determining heparan sulfate and heparin O-sulfotransferase activity and specificity.Electrospray ionization Fourier transform mass spectrometric analysis of intact bikunin glycosaminoglycan from normal human plasma.Changes in composition and sulfation patterns of glycoaminoglycans in renal cell carcinoma.Trypanosoma cruzi heparin-binding proteins mediate the adherence of epimastigotes to the midgut epithelial cells of Rhodnius prolixus.Analysis of glycosaminoglycan-derived, precolumn, 2-aminoacridone-labeled disaccharides with LC-fluorescence and LC-MS detection.Glycosylation of extracellular vesicles: current knowledge, tools and clinical perspectives.Cancer Cell Glycocalyx and Its Significance in Cancer Progression
P2860
Q27013519-E5DD268D-D281-4A18-8B17-E34BBEAD231BQ33649651-B768DAEA-C9DE-4AE3-9840-16F53AB6ED55Q33778582-7D8DA6A3-7BE1-4767-80CE-1EAB13CFEB29Q33900448-C936D2D1-AF70-4AC2-944F-31A139FDE5F9Q34390331-2C5F39EA-09CB-4BCE-9D68-879F07BEC543Q34432774-248754CE-7AE8-40B2-B6B5-012CADAF0DFBQ34507805-5CB128C2-8B5F-4048-B682-3896ACB3307AQ35056506-A93C7FFF-FB82-4667-977A-A4CF1229BEBDQ35400682-3E93A34D-623D-41E3-A6F6-61E1B5689EDDQ35984139-BAE9CDE9-B99F-4B63-94F7-E11C421FF702Q36182371-2AC572B7-E1B8-4A5A-BC56-63389F72C1ABQ36530855-96CBC36C-2B9B-4882-90A3-9970DC84B4C4Q36554714-43EC06CC-4331-4FCB-9071-4ACD0C91D79EQ36771403-DDE0DF38-F9EC-47AE-9E76-7BDCE2D08FF1Q37105366-34369979-C3F0-4C6D-8BB5-278230744194Q37190063-4521E410-0727-477C-ABBF-96561A9F9866Q37683396-F37DC459-E0E7-4726-94AE-7CD429B6B40BQ37686168-591EF855-364D-4D15-9B1A-0A00CF7E6F1AQ37732286-62E39346-4597-4C08-8E1F-A19D34D56292Q38034106-FEB1BD1D-E585-4EBD-B0CD-044A3F42AFF0Q38099033-26DB46E7-2125-4DA3-A29B-F1C75C8EF5DAQ38172280-74CFD0F7-9B96-4024-8BA9-0F30F47ABDDDQ38325965-6D41A698-CC4B-4D7A-8EE0-77606FD21CDEQ38945184-31517F0F-5A99-4886-B4C9-3775C180B486Q38945364-4D4C1524-1C0D-4C1C-934C-308B8022BBF1Q39451157-46BC79A2-E166-4C16-B041-E964E6876464Q41303602-9EA31313-BC16-467C-BADD-E72DB9407CFAQ41878618-44AEA581-5690-41A8-A5C1-1399EA53CBD9Q42103131-635822BB-1F89-45D9-BDE8-DA667D74BDBAQ51608263-AAA4814E-C21B-49AF-BF0E-D9ED9C7C33EBQ52733908-D182A927-3816-46F5-9688-270A84EF5A6FQ53625004-9FD75E23-4648-4816-BBEC-EC6C06A577EEQ55091449-4548F482-35E4-4B8F-B757-2BC876B4D97CQ57168005-DA45D24C-5080-4D75-9519-E84239F466AB
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Proteoglycomics: recent progress and future challenges.
@en
Proteoglycomics: recent progress and future challenges.
@nl
type
label
Proteoglycomics: recent progress and future challenges.
@en
Proteoglycomics: recent progress and future challenges.
@nl
prefLabel
Proteoglycomics: recent progress and future challenges.
@en
Proteoglycomics: recent progress and future challenges.
@nl
P2860
P356
P1476
Proteoglycomics: recent progress and future challenges.
@en
P2093
Mellisa Ly
Tatiana N Laremore
P2860
P304
P356
10.1089/OMI.2009.0123
P577
2010-08-01T00:00:00Z